Showing results (171-180 of 618) with videos related to
Sort By:
Pageof 62
Frontiers in Radiology|December 28, 2023
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integrationFrancesco Sanvito, Timothy J Kaufmann, Timothy F Cloughesy, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2024
Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastomaNathan McDannold, Patrick Y Wen, David A Reardon, et al.Neuro-Oncology|March 19, 2016
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD)Jennifer L Helfer, Patrick Y Wen, Jaishri Blakeley, et al.Neuro-Oncology|October 15, 2014
Pros and cons of current brain tumor imagingBenjamin M Ellingson, Patrick Y Wen, Martin J van den Bent, et al.Neuro-Oncology|February 9, 2022
Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomasJasmin Jo, Martin J van den Bent, Burt Nabors, et al.Journal of Neuro-Oncology|April 18, 2014
The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guidelineJeffrey J Olson, Lakshmi Nayak, D Ryan Ormond, et al.The Journal of Supportive Oncology|August 12, 2005
Suspected spinal cord compression in cancer patients: a multidisciplinary risk assessmentCharles Lu, Ramon G Gonzalez, Ferenc A Jolesz, et al.Expert Opinion on Biological Therapy|March 21, 2008
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapyDavid A Reardon, Patrick Y Wen, Annick Desjardins, et al.Journal of Neuro-Oncology|February 18, 2009
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progressionElizabeth R Gerstner, Margaret B McNamara, Andrew D Norden, et al.Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.Pageof 62